Liminatus Pharma Competitors and Similar CompaniesClear all

Liminatus Pharma's competitors and similar companies include CEL-SCI and ONCOtherapeutics.

	Liminatus Pharma Liminatus Pharma (formerly known as Iris Acquisition) is a pre‑clinical‑stage immuno‑oncology company.	CEL-SCI CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.	ONCOtherapeutics ONCOtherapeutics is a contract research organization that runs multiple clinical trials.
Founding Date	Founding Date 2018	Founding Date 1983	Founding Date 2005
Type	Type Public	Type Public	Type Private
Tags	Tags Healthcare biotech clinical research drug development therapy	Tags Healthcare biotech clinical research drug development therapy	Tags Healthcare biotech clinical research drug development therapy
Locations	Locations La Palma, US HQ	Locations Vienna, US HQ	Locations West Hollywood, US HQ
Employees	Employees 1	Employees N/A	Employees 13
Financial
Net income	Net income ($10.2m) (FY, 2025)	Net income ($25.4m) (FY, 2025)	Net income N/A

For sources of this data, please see the company profile

Vienna, US

CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.

West Hollywood, US

Employees

ONCOtherapeutics is a contract research organization that runs multiple clinical trials.

Financial